Article

Pink ophthalmic lens sales support breast cancer research

Volk Optical and Pioneer International have donated $30,000 to the American Cancer Society after selling 1,000 limited-edition diagnostic and treatment lenses.

Mentor, OH-Ophthalmic lens designer and manufacturer Volk Optical and the distributor of its products, Pioneer International, have donated $30,000 to the American Cancer Society after selling 1,000 of the limited-edition diagnostic and treatment lenses Volk developed in 2009 to support Pioneer’s philanthropic efforts.

The lenses, available in 20-, 78-, and 90-D versions as well as in a digital wide-field model, are ringed in the signature pink of breast cancer awareness and are engraved with the awareness ribbon. They are available exclusively from Pioneer.

The sale of each lens in the line results in $30-$10 of the purchase price and matching funds of $10 each from Volk and Pioneer-being donated to breast cancer research. The campaign originated in observance of Pioneer’s 10th anniversary.

“Statistically, one in eight U.S. women will develop invasive breast cancer over the course of her lifetime,” said Valerie Nicola, founder and chief executive officer of Pioneer. “With this disease [affecting] not only women but the lives of their loved ones, we felt it important to unite with Volk in an effort to support new discoveries and a better understanding of cancer and its treatment.”

To order the lenses, contact Pioneer at 888/206-5380 or visit www.pioneerdoctor.com.

For more articles in this issue of Ophthalmology Times eReport, click here.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
© 2025 MJH Life Sciences

All rights reserved.